Platelet-rich plasma: where are we now and where are we going? - Wikidata - awgldk - TriplyDB

Platelet-rich plasma: where are we now and where are we going?

Platelet-rich plasma: where are we now and where are we going?

http://www.wikidata.org/entity/Q42286512

about

Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective Platelet-rich plasma in meniscal repair: does augmentation improve surgical outcomes?Evaluation of pain regression in patients with temporomandibular dysfunction treated by intra-articular platelet-rich plasma injections: a preliminary report.Pre-stem cell formation by non-platelet RNA-containing particle fusion.Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors Platelet-rich plasma injections for the treatment of refractory Achilles tendinopathy: results at 4 years.Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial.Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro.Platelet-rich plasma peptides: key for regeneration.Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration.A Pilot Study Evaluating the Effectiveness of Platelet-Rich Plasma Therapy for Treating Degenerative Tendinopathies: A Randomized Control Trial with Synchronous Observational Cohort Knee Articular Cartilage Repair and Restoration Techniques: A Review of the Literature Platelet-rich plasma for the treatment of patellar tendinopathy: clinical and imaging findings at medium-term follow-up A multidisciplinary approach including the use of platelet-rich plasma to treat an elite athlete with patellar tendinopathy - a case report.Basic science of anterior cruciate ligament injury and repair.New bio-ceramization processes applied to vegetable hierarchical structures for bone regeneration: an experimental model in sheep.Biologic Approaches for the Treatment of Partial Tears of the Anterior Cruciate Ligament: A Current Concepts Review.A review of modern management of lateral epicondylitis.Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration.Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents.Learning about PRP using cell-based models Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy--a systematic review.Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis.The use of autologous platelet-rich plasma in the orthopedic setting.Therapeutics for tendon regeneration: a multidisciplinary review of tendon research for improved healing Hamstrings anterior cruciate ligament reconstruction with and without platelet rich fibrin matrix.Platelet-Rich Plasma Intra-articular Knee Injections Show No Superiority Versus Viscosupplementation: A Randomized Controlled Trial.EFFECT OF USE OF BONE-MARROW CENTRIFUGATE ON MUSCLE INJURY TREATMENT: EXPERIMENTAL STUDY ON RABBITS.PRP for the treatment of cartilage pathology.Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes?Effect of two different preparations of platelet-rich plasma on synoviocytes.Histological analysis of the association of low level laser therapy and platelet-rich plasma in regeneration of muscle injury in rats.Intra-articular platelet-rich plasma injections for knee osteoarthritis: An overview of systematic reviews and risk of bias considerations.Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL.Conservative management of MRI-confirmed knee osteoarthritis with instrument-assisted soft-tissue mobilization, joint manipulation, and platelet-rich plasma.Kidney regeneration by non-platelet RNA-containing particle-derived cells.Ultrasound biomicroscopy and claudication test for in vivo follow-up of muscle repair enhancement based on platelet-rich plasma therapy in a rat model of gastrocnemius laceration.Fibrin network architectures in pure platelet-rich plasma as characterized by fiber radius and correlated with clotting time.

P2860

Q26858825-377C7711-7085-441C-9780-9BEC56465E46 Q30300838-8EFD028F-CE88-4D61-A04B-780EBFE07AE6 Q30432459-4E152394-D55C-4DD5-89E4-4CAA1934D766 Q30543276-F0128ED6-6ED9-44EC-950D-48FA4615553D Q33575884-B5AA16D3-27EC-4EF2-9FA1-C8930CEE9123 Q34416364-357C3360-AE35-4ADB-B273-16647088C32E Q34486652-24AD5727-59C1-4E40-94D5-D70AA7D32EBA Q34511760-E8FDB088-4AE2-46E0-B04E-03F00DC3EABB Q35049755-58299D10-07D1-409C-B20C-0CDA37795891 Q35724455-00B450E5-A5F2-4350-8421-530CC115F8B6 Q35829738-45514014-1B53-4622-BBAF-ADAA851507F9 Q35910643-CD48DAB8-316D-4669-A2FD-336B14AC2846 Q35916134-5163F2F7-75BB-43F6-8EEB-0152F26C9A5B Q36682485-4CEFDBC1-A219-4E4A-ACBD-31FBE0E4418F Q37057516-D931C0A8-815E-4B17-818F-9D341B246371 Q37353783-1F71A6ED-AD39-4FAB-B3F8-4E8C25BFEF72 Q37579727-F7E4DD52-14BF-4139-BD40-ABDBDF70B303 Q37590700-DB80CB2D-B48A-4B98-8C87-7F1CA56C7D23 Q37632323-684FF8D4-E866-4509-A677-20B271DAB7C2 Q38023631-4075F7D1-15B9-47D7-A745-1EDF88E0BF90 Q38166202-3F268691-017A-421F-A567-A448F2ED7CB3 Q38215383-A6383C47-C1E6-44C2-8235-AA76E0E38F41 Q38220507-AADB3010-5FF8-43A3-9082-01F81BB7C7C6 Q38260840-CE05D4BF-0BA8-45FA-9D71-F0D25A838012 Q38270427-B1765002-DFA8-481E-A9D8-560E6D3C24A0 Q38342305-4F2F4994-D1D1-4E5B-A4E5-33FB142D3774 Q38987521-F0C2CB64-19A9-4B01-87D3-AAF71E57C4DC Q39137342-9ACC9974-7FA9-472E-A914-5248038138A3 Q39189544-8389DFE8-78FD-4388-9C2B-D3917E397FBF Q39200775-2D69FBE9-51E8-47EE-8C3B-B8E8EA23A747 Q41059641-4B0F13D9-064E-4E23-A734-819307095F1E Q41823550-B8A46AFF-E02B-4F3A-BD04-6739FA7027FA Q41980295-4A66FFA3-94AE-4CBB-89CC-9496AB0F06F6 Q46983885-08365AF6-4A4F-4307-86CD-AE4B6B8D517F Q47586640-01FDBF54-D6F9-4BE5-8609-59D91131FB9B Q47863596-8A4CBF73-41B5-4A19-8AA3-18059E9AC2E3 Q50074181-E4C44075-CF69-4820-9378-8F487B901FB6 Q50472985-0BA47D7D-7BDC-4715-A820-F4597A78FDE5 Q51456807-4D2AAFDF-D68A-4672-863B-931745B38BF5 Q53549023-514E74AB-CC83-4C80-8F39-77BEE40FAC44

P2860

Platelet-rich plasma: where are we now and where are we going?

http://www.wikidata.org/entity/Q42286512

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Platelet-rich plasma: where are we now and where are we going?

@en

Platelet-rich plasma: where are we now and where are we going?

@nl

type

label

Platelet-rich plasma: where are we now and where are we going?

@en

Platelet-rich plasma: where are we now and where are we going?

@nl

prefLabel

Platelet-rich plasma: where are we now and where are we going?

@en

Platelet-rich plasma: where are we now and where are we going?

@nl

P1433

Q42286512-BF3173C2-25DD-496C-BD32-5A87135E2257

P1476

Q42286512-AB134595-1641-4D1A-8CE7-8B991C6EB1A0

P2093

Q42286512-441687B3-A4B5-44E4-AB24-312D3438CD37

Q42286512-70643E1E-7D54-4408-80F2-AC9041BC13AC

Q42286512-F6E65D9F-0522-4362-AD4C-EAF9D26F23D7

Q42286512-FAB6421A-6C5B-40B5-9974-60B395867E7F

P2860

Q42286512-0FB337BD-0930-4A3A-A7C1-B2096F2ECA6D

Q42286512-12F117CA-C79C-42C5-B58C-2DC7783E58A6

Q42286512-172340F9-C219-4D87-8B27-C6089FF5CC21

Q42286512-1B04A785-499C-47CF-9C54-BFC270D159D8

Q42286512-1C6B2213-3409-4566-A501-5511FD658D03

Q42286512-1D828DC8-F00A-42EA-B5A7-36AAA4353302

Q42286512-1EF44C12-E61E-45AA-8DCF-C4C845599881

Q42286512-218F74A3-E0CE-472A-A727-A25E94BBE6D1

Q42286512-28264513-915C-4907-9947-DC4774023FE4

Q42286512-2E2DD648-5599-447E-B522-96212735B071

P304

Q42286512-A376BDCB-DC9F-4F10-A5D0-C896B49337BB

P31

Q42286512-BD80BA84-0885-484D-A059-63B148CC180A

P356

Q42286512-E650D3F3-9F17-42DB-9DE7-0A5B16941A98

P433

Q42286512-9A903505-CB9B-40DB-9E13-1DC303D7878E

P478

Q42286512-37A6BD7E-2EAE-4785-B633-14B4E75C23FE

P50

Q42286512-CA06B9A2-5221-497B-ABD4-B6134598C2D4

P577

Q42286512-B528E927-2DBC-488D-9AA1-650DC0671F4F

P5875

Q42286512-4585BAF4-5057-459C-9FC6-A20BA86654EA

P698

Q42286512-D974B971-46CB-4DEF-A302-4F0AD73A3274

P932

Q42286512-C3681F68-2701-484D-BC07-BFDAD18BAE24

P356

1941738110366385

P1433

Sports Health: A Multidisciplinary Approach

P1476

Platelet-rich plasma: where are we now and where are we going?

@en

P2093

Brian J Cole

http://www.w3.org/2001/XMLSchema#string

Lisa A Fortier

http://www.w3.org/2001/XMLSchema#string

Sarvottam Bajaj

http://www.w3.org/2001/XMLSchema#string

Shane T Seroyer

http://www.w3.org/2001/XMLSchema#string

P2860

The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes

Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling.

Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament.

Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments.

Autologous blood injections for refractory lateral epicondylitis.

Platelet-rich plasma: evidence to support its use.

Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors.

Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation.

Treatment of tendon and muscle using platelet-rich plasma.

Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

P304

203-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1941738110366385

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Filardo

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231215628

http://www.w3.org/2001/XMLSchema#string

P698

23015939

http://www.w3.org/2001/XMLSchema#string

P932

3445108

http://www.w3.org/2001/XMLSchema#string